What is the Maximum Dose of Compounded Semaglutide?

Last reviewed: June 4, 2026

Last updated: June 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes that has demonstrated significant weight loss benefits in clinical trials. The maximum dose of compounded semaglutide varies by individual based on tolerance, therapeutic goals, and medical history, not a one-size-fits-all ceiling. PlexusDx works with licensed 503A compounding pharmacies to provide personalized semaglutide therapy tailored to your body's needs.

Understanding Semaglutide Dosing Progression

Semaglutide injections follow a titration schedule, meaning doses begin at a lower level and increase gradually over weeks or months. This stepwise approach allows your body to adapt to the medication while PlexusDx providers monitor your response and any side effects. Most patients start at 0.25 mg weekly, with increases occurring every four weeks if tolerated well. The goal is to find your optimal therapeutic dose—the amount that delivers meaningful weight loss while keeping you comfortable.

Your dose may need to go up as your body adjusts or as your weight loss goals require additional metabolic support. However, your monthly PlexusDx price remains flat regardless of dose level, meaning increases in strength do not increase your monthly cost. This pricing model removes barriers to reaching an effective dose safely and gradually.

What is the Medical Maximum for Compounded Semaglutide?

The maximum dose of semaglutide used in clinical weight loss programs typically ranges from 1.0 to 2.4 mg administered once weekly. This upper range reflects doses studied in the STEP trials, which evaluated semaglutide's efficacy and safety in people with obesity or weight-related conditions. However, not every patient requires or tolerates the highest dose—many achieve meaningful results at 0.5 mg to 1.0 mg weekly.

PlexusDx providers determine your personal maximum dose based on your medical history, current medications, kidney and liver function, and how well you tolerate each dose increase. Some patients plateau at lower doses due to excellent response, while others may titrate higher over months if their metabolic needs warrant it. The decision always prioritizes your safety and sustained weight loss rather than reaching an arbitrary ceiling.

Factors That Influence Your Maximum Safe Dose

The PlexusDx Precision Peptide Genetic Test analyzes MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Other clinical factors include your current weight, previous medication responses, gastrointestinal tolerance, kidney function, and whether you take other medications that interact with semaglutide. Age, activity level, and baseline metabolism also inform dosing decisions. PlexusDx coordinates with your primary care provider or our medical team to ensure your maximum dose aligns with your overall health profile and weight loss objectives.

Staying Within Safe Limits While Maximizing Results

Going beyond recommended maximum doses does not improve weight loss and increases the risk of side effects such as nausea, vomiting, pancreatitis, or thyroid complications. Clinical evidence supports that semaglutide's weight loss benefits plateau at standard therapeutic doses, meaning higher doses do not necessarily mean better outcomes. PlexusDx providers adhere to evidence-based guidelines and your individual tolerance to ensure you reach an effective dose without unnecessary risk.

If you experience persistent side effects at a given dose, your PlexusDx provider may hold your dose steady, reduce it slightly, or switch you to an alternative compound like tirzepatide or oral semaglutide. The goal is sustainable, safe weight loss, not reaching an arbitrary maximum. Your monthly price remains consistent throughout any dose adjustments or compound switches, supporting your long-term adherence to treatment.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Will my PlexusDx price increase if my semaglutide dose goes up?

No. PlexusDx charges a flat monthly rate for compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan, regardless of your dose level. Your dose may need to go up—your price won't. This pricing structure ensures you can titrate safely to your optimal therapeutic dose without cost barriers.

What does the research say about maximum semaglutide doses for weight loss?

The STEP clinical trials demonstrated that 2.4 mg once weekly achieved the greatest weight loss benefit in people with obesity, with an average loss of around 18% body weight over 68 weeks. However, meaningful results occurred at lower doses (0.5 to 1.0 mg) for many participants.

How does PlexusDx determine my maximum semaglutide dose?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Are compounded semaglutide doses safe up to 2.4 mg weekly?

Semaglutide at 2.4 mg weekly has been studied and shown safe in clinical trials, but safety depends on your individual health profile, kidney function, and tolerance. Compounded semaglutide from PlexusDx's licensed 503A pharmacies must meet the same pharmaceutical standards as branded versions.

How can the Precision Peptide Genetic Test help set my ideal semaglutide dose?

The Precision Peptide Genetic Test examines 14 metabolic pathways and 150+ genetic insights, including GIPR variants that influence how your body responds to semaglutide. Patients with certain GLP1R variants may achieve stronger appetite suppression at lower doses, while others may benefit from higher titration.

Related Reading

• Semaglutide Starting Dose
• Compounded Semaglutide 2
• Compounded Semaglutide
• Medvi Semaglutide

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.